Noema Pharma raises crucial financing for treatments
Company has raised $112m in order to develop therapies for central nervous system disorders
Read Moreby John Pinching | Mar 7, 2023 | News | 0
Company has raised $112m in order to develop therapies for central nervous system disorders
Read Moreby John Pinching | Jan 19, 2023 | News | 0
The new funding package will be used to progress NeoPhore’s expanding pipeline of therapies
Read Moreby Lucy Parsons | Jul 15, 2021 | News | 0
Investment raised by its spinouts more than doubled in the last year, the charity has reported
Read Moreby Lucy Parsons | May 5, 2021 | News | 0
Funds will be used to advance company’s integrated physiological and digital biomarker platform
Read Moreby Lucy Parsons | Jan 26, 2021 | News | 0
Biopharma company has raised approximately £33m to date
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
